en.Wedoany.com Reported - Valiant Energy Management (referred to as Valiant) has announced the acquisition of VanDeMark Chemical (referred to as VDM), a 75-year-old U.S. specialty chemicals manufacturer. The transaction preserves the existing operations of VDM's Lockport, New York facility and lays the foundation for future investment and business expansion.
Founded in 1951, VanDeMark Chemical is one of the oldest producers of phosgene derivatives and specialty chemical intermediates in North America, serving customers in the defense, pharmaceutical, agricultural, industrial, biotechnology, and specialty chemicals sectors. The company has built a market reputation based on its technical expertise, manufacturing capabilities, and long-standing commitment to safety, quality, and customer service, and is regarded as a critical component of the U.S. domestic specialty chemicals supply chain.
Valiant CEO Nigel Solida stated that the company holds great respect for VanDeMark's employees, capabilities, and history, and believes that VDM possesses a unique combination of technical expertise, manufacturing infrastructure, and market opportunities. He emphasized that Valiant plans to be an active owner, working with the team to invest in the business, solve problems, and create conditions for long-term growth.
This transaction ensures the continuation of one of North America's most unique specialty chemicals manufacturing platforms, preserving critical domestic production capacity serving key end markets such as defense, pharmaceuticals, biotechnology, agriculture, and specialty industries. Valiant plans to take an active operational role in the business, working closely with employees, customers, and suppliers to strengthen operations, invest in manufacturing capabilities, and support innovation.
Valiant CFO Scott Bernstein stated that the transaction aligns with Valiant's investment philosophy of seeking opportunities with strong fundamentals, talented people, and the potential to benefit from active ownership and long-term investment. He noted that VanDeMark possesses unique technical capabilities, long-standing customer relationships, a highly skilled workforce, and significant growth opportunities, and is well-positioned to benefit from favorable trends in the defense, pharmaceutical, biotechnology, and specialty industrial markets.
As part of the acquisition, Valiant plans to maintain and expand operations at the Lockport facility while seeking to enhance manufacturing capabilities, develop new products, strengthen customer relationships, and gradually expand the business. In the transaction, Young & Partners' Peter Young and Stephen Floyd served as financial advisors to Valiant, Blank Rome LLP served as legal counsel, Ryan Haddad served as lead transaction advisor, and Balmoral Advisors served as financial advisor to the seller.
This article is compiled by Wedoany. All AI citations must indicate the source as "Wedoany". If there is any infringement or other issues, please notify us promptly, and we will modify or delete it accordingly. Email: news@wedoany.com
